Elastic power but not driving power is the key promoter of ventilator-induced lung injury in experimental acute respiratory distress syndrome.
Acute respiratory distress syndrome
Alveolar collapse
Inflammation
Ventilator-induced lung injury
Ventilatory power
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
03 06 2020
03 06 2020
Historique:
received:
21
03
2020
accepted:
20
05
2020
entrez:
5
6
2020
pubmed:
5
6
2020
medline:
14
1
2021
Statut:
epublish
Résumé
We dissected total power into its primary components to resolve its relative contributions to tissue damage (VILI). We hypothesized that driving power or elastic (dynamic) power offers more precise VILI risk indicators than raw total power. The relative correlations of these three measures of power with VILI-induced histologic changes and injury biomarkers were determined using a rodent model of acute respiratory distress syndrome (ARDS). Herein, we have significantly extended the scope of our previous research. Data analyses were performed in male Wistar rats that received endotoxin intratracheally to induce ARDS. After 24 h, they were randomized to 1 h of volume-controlled ventilation with low V Driving power was higher at PEEP-11 than other PEEP levels. Dynamic power and total power increased progressively from PEEP-5.5 and PEEP-7.5, respectively, to PEEP-11. Driving power, dynamic power, and total power each correlated with the majority of VILI indicators. However, when correlations were performed from PEEP-3 to PEEP-9.5, no relationships were observed between driving power and VILI indicators, whereas dynamic power and total power remained well correlated with CC-16 expression, alveolar collapse, and lung hyperinflation. In this mild-moderate ARDS model, dynamic power, not driving power alone, emerged as the key promoter of VILI. Moreover, hazards from driving power were conditioned by the requirement to pass a tidal stress threshold. When estimating VILI hazard from repeated mechanical strains, PEEP must not be disregarded as a major target for modification.
Sections du résumé
BACKGROUND
We dissected total power into its primary components to resolve its relative contributions to tissue damage (VILI). We hypothesized that driving power or elastic (dynamic) power offers more precise VILI risk indicators than raw total power. The relative correlations of these three measures of power with VILI-induced histologic changes and injury biomarkers were determined using a rodent model of acute respiratory distress syndrome (ARDS). Herein, we have significantly extended the scope of our previous research.
METHODS
Data analyses were performed in male Wistar rats that received endotoxin intratracheally to induce ARDS. After 24 h, they were randomized to 1 h of volume-controlled ventilation with low V
RESULTS
Driving power was higher at PEEP-11 than other PEEP levels. Dynamic power and total power increased progressively from PEEP-5.5 and PEEP-7.5, respectively, to PEEP-11. Driving power, dynamic power, and total power each correlated with the majority of VILI indicators. However, when correlations were performed from PEEP-3 to PEEP-9.5, no relationships were observed between driving power and VILI indicators, whereas dynamic power and total power remained well correlated with CC-16 expression, alveolar collapse, and lung hyperinflation.
CONCLUSIONS
In this mild-moderate ARDS model, dynamic power, not driving power alone, emerged as the key promoter of VILI. Moreover, hazards from driving power were conditioned by the requirement to pass a tidal stress threshold. When estimating VILI hazard from repeated mechanical strains, PEEP must not be disregarded as a major target for modification.
Identifiants
pubmed: 32493362
doi: 10.1186/s13054-020-03011-4
pii: 10.1186/s13054-020-03011-4
pmc: PMC7271482
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
284Références
Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):38
pubmed: 31346828
Intensive Care Med. 2018 Nov;44(11):1914-1922
pubmed: 30291378
J Appl Physiol. 1970 May;28(5):596-608
pubmed: 5442255
Anesthesiology. 2018 Jun;128(6):1193-1206
pubmed: 29489470
Ann Transl Med. 2018 Oct;6(19):394
pubmed: 30460268
Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):463-8
pubmed: 10673186
Anesthesiology. 2015 Aug;123(2):423-33
pubmed: 26039328
Front Physiol. 2018 Apr 04;9:318
pubmed: 29670537
N Engl J Med. 2015 Feb 19;372(8):747-55
pubmed: 25693014
Anesthesiology. 2016 May;124(5):1100-8
pubmed: 26872367
Intensive Care Med. 2016 Oct;42(10):1597-1600
pubmed: 27637717
PLoS One. 2013;8(1):e53934
pubmed: 23326543
Crit Care Med. 2008 Jun;36(6):1900-8
pubmed: 18496360
Intensive Care Med Exp. 2015 Dec;3(1):34
pubmed: 26671060
N Engl J Med. 2013 Nov 28;369(22):2126-36
pubmed: 24283226
Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):357-62
pubmed: 10934053
Am J Respir Crit Care Med. 2020 Apr 1;201(7):767-774
pubmed: 31665612
Anesthesiology. 2019 Jan;130(1):119-130
pubmed: 30277932
Am J Respir Crit Care Med. 2005 Jun 15;171(12):1328-42
pubmed: 15695492
Anesthesiology. 2020 May;132(5):1126-1137
pubmed: 32032095
Anesthesiology. 2019 May;130(5):767-777
pubmed: 30870161
Eur Respir J. 2017 Jul 5;50(1):
pubmed: 28679607